LifeSiteNews has produced an extensive COVID-19 vaccines resources page. View it here.
May 17, 2021 (LifeSiteNews) – A group of Israeli researchers conducting a study into immunity against COVID-19 found that protection from the virus is no more robust after injection with Pfizer’s experimental mRNA vaccine than that gained after recovering from previous infection, compelling them to “question the need to vaccinate previously-infected individuals.”
The research team, comprising academics from the Israel Institute of Technology, the Sheba Medical Center, Tel Aviv University, and The Hebrew University of Jerusalem, included the entire population of Israel in its study “to assess the protection efficacy of both prior infection and vaccination in preventing subsequent SARS-CoV-2 infection, hospitalization with COVID-19, severe disease, and death due to COVID-19.”
The three-month study – following four sets of groups based on a variation of being vaccinated, unvaccinated, previously infected, and not previously infected – showed that the overall efficacy of Pfizer’s mRNA vaccine against infection was 92.8 percent, ranking marginally lower than natural immunity from prior infection, which the study found to be 94.8 percent.
Additionally, previous infection with the virus was found to provide slightly more protection against severe illness upon re-infection than vaccination in those
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors